Legally Reviewed and Fact Checked by: Emily Weinberger , Attorney
If you or a loved one used Depo-Provera for birth control and have since been diagnosed with meningioma, you may be entitled to financial compensation.
At Serling & Abramson, P.C., we are actively reviewing cases related specifically to meningioma diagnoses linked to Depo-Provera use. While this contraceptive has been widely prescribed for decades, new studies are now exposing serious long-term health risks that were not properly communicated to patients.
Depo-Provera is a prescription birth control shot that’s administered every 12 weeks. It contains medroxyprogesterone acetate, a synthetic form of the hormone progestin. The injection prevents pregnancy by:
Depo-Provera is praised for its convenience and long-lasting effects, often chosen by women who prefer not to take a daily pill. It’s also used off-label to treat conditions like endometriosis or irregular periods.
But despite its widespread use, Depo-Provera is now under scrutiny for serious health risks—particularly a connection to meningiomas, a type of brain tumor.
A meningioma is a tumor that forms in the meninges, which are the membranes surrounding your brain and spinal cord. While most meningiomas are benign (non-cancerous), that doesn’t mean they’re harmless.
Depending on their size and location, meningiomas can lead to life-altering symptoms, including:
Meningiomas are the most common type of primary brain tumor in adults, and they often require surgical removal, radiation, or ongoing monitoring. In severe cases, they can be disabling or even fatal.
So, what’s the connection?
Several studies in recent years have found a statistically significant association between long-term use of Depo-Provera and the development of meningiomas.
In particular:
Despite the emerging data, many patients were never warned about this serious side effect.
If you have used Depo-Provera for over 1 year, Depo-Provera may increase the risk of brain tumors called meningiomas by more than 5 times, according to the National Library of Medicine.
Patients may be able to file a Depo shot lawsuit against Pfizer, the drug’s manufacturer, for failing to warn them about potential dangers.
You may qualify for a lawsuit if all of the following apply to you:
At this time, our office is only accepting cases involving diagnosed meningioma tumors.
If your case is successful, you may be entitled to compensation for:
Every case is different, and the compensation will depend on your individual circumstances.
Pharmaceutical companies have a legal and ethical obligation to warn patients about the known dangers of their products. When they fail to do so, and real people suffer life-altering consequences, they must be held accountable.
Women trusted that Depo-Provera was a safe option for long-term birth control. Many used it for years—only to learn later that it may have contributed to the growth of a brain tumor.
This is unacceptable.
At Serling & Abramson, P.C., we have over five decades of experience handling complex mass tort and pharmaceutical injury cases. Our firm has earned a national reputation for standing up to powerful drug companies on behalf of injured patients.
Here’s why thousands have trusted us:
We handle every case with compassion, tenacity, and a commitment to getting results. You’ll never be just another case file to us—you’re a person who deserves justice.
If you’re considering legal action, here are the steps to take:
Each state has a statute of limitations, meaning you only have a certain amount of time to file a lawsuit after your diagnosis. If you wait too long, you could lose your right to seek justice and compensation.
Even if you’re unsure whether you qualify, it’s better to speak with a lawyer sooner rather than later.
If you or a loved one were diagnosed with a meningioma after using Depo-Provera, contact Serling & Abramson, P.C. today for a free, confidential case review. You may be entitled to significant compensation—and we’re here to help you fight for it.
Call us now or fill out our online form to get started.